GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (NYSE:ZBH) » Definitions » Cyclically Adjusted Price-to-FCF

Zimmer Biomet Holdings (Zimmer Biomet Holdings) Cyclically Adjusted Price-to-FCF : 17.00 (As of Apr. 27, 2024)


View and export this data going back to 2001. Start your Free Trial

What is Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Zimmer Biomet Holdings's current share price is $119.35. Zimmer Biomet Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $7.02. Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF for today is 17.00.

The historical rank and industry rank for Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

ZBH' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 13.16   Med: 20.8   Max: 26.8
Current: 17.05

During the past years, Zimmer Biomet Holdings's highest Cyclically Adjusted Price-to-FCF was 26.80. The lowest was 13.16. And the median was 20.80.

ZBH's Cyclically Adjusted Price-to-FCF is ranked better than
80.35% of 229 companies
in the Medical Devices & Instruments industry
Industry Median: 42.75 vs ZBH: 17.05

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Zimmer Biomet Holdings's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $2.521. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $7.02 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF Chart

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 22.92 23.76 18.45 18.54 17.33

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.54 18.48 20.73 16.02 17.33

Competitive Comparison of Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF falls into.



Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=119.35/7.02
=17.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zimmer Biomet Holdings's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Zimmer Biomet Holdings's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.521/129.4194*129.4194
=2.521

Current CPI (Dec. 2023) = 129.4194.

Zimmer Biomet Holdings Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 0.916 99.695 1.189
201406 1.299 100.560 1.672
201409 1.301 100.428 1.677
201412 1.815 99.070 2.371
201503 0.330 99.621 0.429
201506 0.964 100.684 1.239
201509 0.218 100.392 0.281
201512 2.016 99.792 2.615
201603 1.213 100.470 1.563
201606 1.673 101.688 2.129
201609 1.460 101.861 1.855
201612 2.825 101.863 3.589
201703 1.144 102.862 1.439
201706 2.012 103.349 2.520
201709 2.096 104.136 2.605
201712 1.749 104.011 2.176
201803 2.267 105.290 2.787
201806 1.790 106.317 2.179
201809 2.057 106.507 2.500
201812 1.627 105.998 1.987
201903 1.194 107.251 1.441
201906 0.216 108.070 0.259
201909 2.509 108.329 2.997
201912 1.787 108.420 2.133
202003 1.989 108.902 2.364
202006 -0.347 108.767 -0.413
202009 1.682 109.815 1.982
202012 1.941 109.897 2.286
202103 1.050 111.754 1.216
202106 2.037 114.631 2.300
202109 1.848 115.734 2.067
202112 1.466 117.630 1.613
202203 0.956 121.301 1.020
202206 1.482 125.017 1.534
202209 1.919 125.227 1.983
202212 0.858 125.222 0.887
202303 1.240 127.348 1.260
202306 0.845 128.729 0.850
202309 1.144 129.860 1.140
202312 2.521 129.419 2.521

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zimmer Biomet Holdings  (NYSE:ZBH) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Zimmer Biomet Holdings Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (Zimmer Biomet Holdings) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.
Executives
Syed A. Jafry director 345 E. MAIN STREET, WARSAW IN 46580
Sreelakshmi Kolli director C/O ALIGN TECHNOLOGY INC., 2820 ORCHARD PARKWAY, SAN JOSE CA 94131
Christopher B Begley director
Robert Hagemann director 3 GIRALDA FARMS, MADISON NJ 07940
Michael W Michelson director 2800 SAND HILL ROAD, SUITE 200, MENLO PARK CA 94025
Betsy J Bernard director 711 HIGH STREET, DES MOINES IA 50392-0300
Arthur J Higgins director C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Chad F Phipps officer: Assoc. Gen. Counsel, Corp. Sec C/O ZIMMER, INC., P.O. BOX 708, WARSAW IN 46580
Zuilen Wilfred Van officer: Pres, Europe, M. East & Africa 345 E. MAIN STREET, WARSAW IN 46580
Paul A Stellato officer: VP, Controller & CAO C/O XYLEM INC, 1 INTERNATIONAL DRIVE, RYE BROOK NY 10573
Sang Yi officer: President, Asia Pacific 345 E. MAIN STREET, WARSAW IN 46580
Lori Winkler officer: SVP and CHRO 345 E. MAIN STREET, WARSAW IN 46580
Rachel Ellingson officer: SVP & CSO 345 E MAIN STREET, WARSAW K7 46580
Bryan C Hanson director, officer: President and CEO ZIMMER BIOMET HOLDINGS, 345 E. MAIN STREET, WARSAW IN 46580
Aure Bruneau officer: Group President 345 E. MAIN STREET, WARSAW IN 46580